Hudson Bay Capital Management’s Edwards Lifesciences EW Stock Holding History

Hudson Bay Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$42.6M	Sell	532,100 -129,500	-20%	-$10.7M	0.15%	118
2025 Q4	$56.4M	Sell	661,600 -271,120	-29%	-$22.2M	0.19%	100
2025 Q3	$72.5M	Sell	932,720 -1,729	-0.2%	-$135K	0.24%	71
2025 Q2	$73.1M	Buy	+934,449	New	+$69.7M	0.25%	78
2018 Q2	–	Sell	-10,200	Closed	-$474K	–	847
2018 Q1	$474K	Buy	+10,200	New	+$443K	0.01%	675

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Hudson Bay Capital Management's EW Position: Q1 2026 in Review

Hudson Bay Capital Management reduced its Edwards Lifesciences (EW) stake by 20% in Q1 2026, selling an estimated $10.7M and leaving 532,100 shares worth $42.6M. The position accounts for 0.15% of the portfolio, ranked #118.

Hudson Bay Capital Management first reported a position in EW in Q1 2018 and has held it in 5 quarters since. The position peaked at $73.1M in Q2 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Hudson Bay Capital Management held 532,100 shares of Edwards Lifesciences worth $42.6M as of Q1 2026.
Hudson Bay Capital Management sold 129,500 Edwards Lifesciences shares in Q1 2026, an estimated $10.7M.
Edwards Lifesciences made up 0.15% of Hudson Bay Capital Management's portfolio in Q1 2026, its #118 holding.
Hudson Bay Capital Management first reported a position in Edwards Lifesciences in Q1 2018 and has held it in 5 quarters since.
Hudson Bay Capital Management's Edwards Lifesciences position peaked at $73.1M in Q2 2025.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.